CD36 and atherosclerosis: The ability to purify full-length SR-B1 and CD36, as well as verify their functionality, creates new opportunities to understand receptor dynamics and provides a necessary step toward understanding the molecular mechanisms behind lipid transport and atherosclerosis development.